Touyun Biotech Group Limited (1332.HK)

HKD 0.17

(0.0%)

EBITDA Summary of Touyun Biotech Group Limited

Touyun Biotech Group Limited's latest annual EBITDA in 2023 was -228.56 Million HKD , down -915.14% from previous year.
Touyun Biotech Group Limited's latest quarterly EBITDA in 2024 Q2 was -27.55 Million HKD , down 0.0% from previous quarter.
Touyun Biotech Group Limited reported an annual EBITDA of -144.39 Million HKD in 2022, up 152.3% from previous year.
Touyun Biotech Group Limited reported an annual EBITDA of -83.12 Million HKD in 2021, up 71.81% from previous year.
Touyun Biotech Group Limited reported a quarterly EBITDA of -28.78 Million HKD for 2023 Q4, down 0.0% from previous quarter.
Touyun Biotech Group Limited reported a quarterly EBITDA of -24.94 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Touyun Biotech Group Limited (2023 - 2011)

Historical Annual EBITDA of Touyun Biotech Group Limited (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	-228.56 Million HKD	-915.14%
2022	-144.39 Million HKD	152.3%
2021	-83.12 Million HKD	71.81%
2020	-87.22 Million HKD	50.98%
2019	-197.68 Million HKD	23.1%
2018	-181.66 Million HKD	33.08%
2017	-233.9 Million HKD	72.38%
2016	-1.09 Billion HKD	-396.78%
2015	259.49 Million HKD	-856.96%
2014	18 Million HKD	-16.91%
2013	20.54 Million HKD	-29.51%
2012	29.13 Million HKD	-41.05%
2011	49.42 Million HKD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-27.55 Million HKD	0.0%
2023 Q4	-28.78 Million HKD	0.0%
2023 Q2	-24.94 Million HKD	0.0%
2023 FY	- HKD	-915.14%
2022 Q4	-5.46 Million HKD	0.0%
2022 Q2	-3.86 Million HKD	0.0%
2022 FY	- HKD	152.3%
2021 FY	- HKD	71.81%
2021 Q4	1.27 Million HKD	0.0%
2021 Q2	-9.74 Million HKD	0.0%
2020 FY	- HKD	50.98%
2020 Q2	-19.7 Million HKD	0.0%
2020 Q4	-12.98 Million HKD	0.0%
2019 Q4	-1.64 Million HKD	0.0%
2019 FY	- HKD	23.1%
2019 Q2	-3.01 Million HKD	0.0%
2018 Q4	-59.42 Million HKD	0.0%
2018 Q2	-66.18 Million HKD	0.0%
2018 FY	- HKD	33.08%
2017 Q2	-97.02 Million HKD	0.0%
2017 Q4	-28.21 Million HKD	0.0%
2017 FY	- HKD	72.38%
2016 FY	- HKD	-396.78%
2016 Q4	- HKD	0.0%
2016 Q2	-231 Million HKD	0.0%
2015 FY	- HKD	-856.96%
2015 Q4	-53.26 Million HKD	0.0%
2015 Q2	-45.93 Million HKD	0.0%
2014 Q4	9.97 Million HKD	0.0%
2014 Q2	6.63 Million HKD	0.0%
2014 FY	- HKD	-16.91%
2013 FY	- HKD	-29.51%
2013 Q4	9.46 Million HKD	0.0%
2013 Q2	12.35 Million HKD	0.0%
2012 FY	- HKD	-41.05%
2012 Q2	- HKD	0.0%
2012 Q4	- HKD	0.0%
2011 FY	- HKD	0.0%

Peer EBITDA Comparison of Touyun Biotech Group Limited

Name	EBITDA	EBITDA Difference
Starlite Holdings Limited	71.42 Million HKD	419.993%
Litu Holdings Limited	1.21 Million HKD	18958.746%
Champion Alliance International Holdings Limited	35.89 Million HKD	736.715%
Huaxi Holdings Company Limited	-31.47 Million HKD	-626.097%